Abstract | OBJECTIVE: METHODS: Sixty cases of CHF were randomly divided into Qiangxin Mixture group (treatment group, n=30) and digoxin group (control group, n=30). The total clinical effective rate, integra of the symptoms of kidney deficiency, classification of functional capacity of the New York Heart Association (NYHA), and echocardiogram [ejection fraction (EF), cardiac output (CO), interventricular septal thickness (IVST), posterior wall thickness (PWT), left ventricular mass index (LVMI)] as well as the measurement of plasma endothelin, angiotensin II and atrial natriuretic peptide were observed in both groups. RESULTS: The total clinical effective rate of Qiangxin Mixture group was 87%, and improvement was significantly observed in the Lee CHF score, classification of functional capacity of the NYHA, EF and CO (P<0.05, vs before treatment), but no significant improvement in digoxin group (P>0.05). The integra of the symptoms of kidney deficiency, the levels of plasma ET, Ang II and ANP decreased significantly (P<0.01, vs before treatment and digoxin group respectively). IVST, PWT and LVMI were also reduced significantly (P<0.01, vs before treatment; P<0.05 vs digoxin group). CONCLUSION: The Qiangxin Mixture is effective in enhancing cardiac contraction, improving hemodynamics in the short-term and rectifying some indexes in the long-term, so it could postpone the processes of CHF. This mechanism may be related to decreasing the stimulating factors ( angiotensin, endothelin) which trigger the cardiac remodeling, delaying or reversing the cardiac remodeling.
|
Authors | Zhao-Shan Chen, Yao-Rong Dong, Wan-Ying Hu |
Journal | Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
(Zhong Xi Yi Jie He Xue Bao)
Vol. 1
Issue 1
Pg. 25-9
(May 2003)
ISSN: 1672-1977 [Print] China |
PMID | 15339608
(Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Drug Combinations
- Drugs, Chinese Herbal
- qiangxin
|
Topics |
- Aged
- Drug Combinations
- Drugs, Chinese Herbal
(therapeutic use)
- Female
- Heart Failure
(drug therapy)
- Humans
- Male
- Middle Aged
- Phytotherapy
- Prognosis
|